Axsome Therapeutics (AXSM) had its Relative Strength (RS) Rating upgraded from 69 to 74 Tuesday — a welcome improvement, but still shy of the 80 or higher score you prefer to see. Can You Really Time The Stock Market? IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's…